These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 938266)

  • 1. Neuroelectric blocking factors in multiple sclerosis and normal human sera.
    Seil FJ; Leiman AL; Kelly JM
    Arch Neurol; 1976 Jun; 33(6):418-22. PubMed ID: 938266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue culture studies of neuroelectric blocking factors.
    Seil FJ
    Adv Neurol; 1981; 31():281-8. PubMed ID: 7325045
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cord.
    Schauf CL; Davis FA; Sack DA; Reed BJ; Kesler RL
    J Neurol Neurosurg Psychiatry; 1976 Jul; 39(7):680-5. PubMed ID: 1086889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural blocking activity of multiple sclerosis and EAE sera.
    Davis FA; Schauf CL
    Neurology; 1976 Jun; 26(6 PT 2):43-4. PubMed ID: 1083963
    [No Abstract]   [Full Text] [Related]  

  • 5. The occurrence, specificity, and role of neuroelectric blocking factors in multiple sclerosis.
    Schauf CL; Davis FA
    Neurology; 1978 Sep; 28(9 Pt 2):34-9. PubMed ID: 568750
    [No Abstract]   [Full Text] [Related]  

  • 6. Depression of complex bioelectric discharges in cerebral tissue cultures by thermolabile complement-dependent serum factors.
    Crain SM; Bornstein MB
    Exp Neurol; 1975 Oct; 49(1 Pt 1):330-5. PubMed ID: 52559
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte subpopulations in multiple scerlosis: comparison with neuroelectric blocking activity.
    Schauf CL; Schauf V; Davis FA; Strelkauskas AJ; Mizen MR
    Neurology; 1977 Sep; 27(9):822-6. PubMed ID: 302431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls.
    Hirayama M; Lisak RP; Silberberg DH
    Neurology; 1986 Feb; 36(2):276-8. PubMed ID: 3945400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatosensory evoked responses in multiple sclerosis patients with varying sensory loss.
    Namerow NS
    Neurology; 1968 Dec; 18(12):1197-204. PubMed ID: 5751349
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 1, 1-dimethylhydrazine (UDMH) on evoked cerebral neuroelectric responses. AMRL-TR-67-67.
    Goff WR; Allison T; Matsumiya Y; Sterman MB; Fairchild MD
    AMRL TR; 1967 May; ():1-10. PubMed ID: 5302471
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum from patients with multiple sclerosis affects electrical activity in neocortical slices of guinea pigs.
    Zhadin MN; Zakharova NM; Andreev AA; Balakin VE; Parkhomenko RI; Slabospitskaya EA
    Bull Exp Biol Med; 2000 Jul; 130(7):655-7. PubMed ID: 11140578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-dependent serum: neuroelectric blocking activity in multiple sclerosis.
    Schauf CL; Schauf V; Davis FA; Mizen MR
    Neurology; 1978 May; 28(5):426-30. PubMed ID: 306076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis.
    Stefoski D; Schauf CL; McLeod BC; Haywood CP; Davis FA
    Neurology; 1982 Aug; 32(8):904-7. PubMed ID: 7201588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologic basis for neuroelectric blocking activity in multiple sclerosis.
    Schauf CL; Pencek TL; Davis FA; Rooney MW
    Neurology; 1981 Oct; 31(10):1337-41. PubMed ID: 6287352
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum demyelinating factors in multiple sclerosis.
    Seil FJ; Westall FC; Romine JS; Salk J
    Ann Neurol; 1983 Jun; 13(6):664-7. PubMed ID: 6192755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatosensory recovery functions in multiple sclerosis patients.
    Namerow NS
    Neurology; 1970 Aug; 20(8):813-7. PubMed ID: 5465850
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-synaptic antibody in allergic encephalomyelitis. II. The synapse-blocking effects in tissue culture of demyelinating sera from experimental allergic encephalomyelitis.
    Lumsden CE; Howard L; Aparicio SR; Bradbury M
    Brain Res; 1975 Aug; 93(2):283-99. PubMed ID: 51671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic brain stimulation: central motor conduction studies in multiple sclerosis.
    Hess CW; Mills KR; Murray NM; Schriefer TN
    Ann Neurol; 1987 Dec; 22(6):744-52. PubMed ID: 3435084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical fragility of erythrocytes in multiple sclerosis.
    Schauf CL; Frischer H; Davis FA
    Neurology; 1980 Mar; 30(3):323-5. PubMed ID: 7189035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ether on evoked potentials of cerebral cortex under conditions of hexenal narcosis].
    Aganiants EK
    Farmakol Toksikol; 1969; 32(1):8-10. PubMed ID: 5770326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.